Pimobendan
Online Access:
Subscribe
This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
-
Häggström J ,Boswood A ,O’Grady MR et al. (2008)Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST Study. Journal of Veterinary Internal Medicine 22 ,1124–1135
-
Summerfield NJ ,Boswood A ,O’Grady MR et al. (2012)Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (The PROTECT Study). Journal of Veterinary Internal Medicine 26 ,1337–1349
-
Boswood A, Häggström J, Gordon SG et al. (2016) Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC Study—a randomized clinical trial.Journal of Veterinary Internal Medicine 30, 1765–1779
-
Boswood A, Grady MO, Jo O et al. (2008). Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.Journal of Veterinary Internal Medicine 22, 1124–1135
-
Lombard CW, Jöns O and Bussadori CM (2006) Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.Journal of the American Animal Hospital Association 42, 249–261
-
Luis Fuentes V, Corcoran B, French A et al. (2002) A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy.Journal of Veterinary Internal Medicine 16, 255–261
-
Smith PJ, French AT, Van Israr̈l N et al. (2005) Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease.Journal Small Animal Practice 46, 121–130